3D90 - Header Asymmetric Unit

HEADER TRANSCRIPTION 26-MAY-08 3D90

TITLE CRYSTAL STRUCTURE OF THE HUMAN PROGESTERONE RECEPTOR LIGAND- TITLE 2 BINDING DOMAIN BOUND TO LEVONORGESTREL

COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROGESTERONE RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: LIGAND-BINDING DOMAIN, UNP RESIDUES 676-933; COMPND 5 SYNONYM: PR, NUCLEAR RECEPTOR SUBFAMILY 3 GROUP C MEMBER 3; COMPND 6 ENGINEERED: YES

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL_LINE: UV20HL21-27; SOURCE 6 GENE: PGR, NR3C3; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21 CODON PLUS (DE3) RIL; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PGEXHPRLBD

KEYWDS PROGESTERONE RECEPTOR, STEROID RECEPTOR, NUCLEAR RECEPTOR, KEYWDS 2 TRANSCRIPTION FACTOR, WOMEN HEALTH, CONTRACEPTION, KEYWDS 3 ALTERNATIVE SPLICING, DNA-BINDING, LIPID-BINDING, METAL- KEYWDS 4 BINDING, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, KEYWDS 5 STEROID-BINDING, TRANSCRIPTION, TRANSCRIPTION REGULATION, KEYWDS 6 ZINC, ZINC-FINGER

EXPDTA X-RAY DIFFRACTION

AUTHOR I.PETIT-TOPIN,N.TURQUE,A.ULMAN,E.GAINER,M.E.RAFESTIN-OBLIN, AUTHOR 2 J.FAGART

REVDAT 2 02-JUN-09 3D90 1 JRNL REVDAT 1 26-MAY-09 3D90 0

JRNL AUTH I.PETIT-TOPIN,N.TURQUE,J.FAGART,M.FAY,A.ULMANN, JRNL AUTH 2 E.GAINER,M.E.RAFESTIN-OBLIN JRNL TITL MET909 PLAYS A KEY ROLE IN THE ACTIVATION OF THE JRNL TITL 2 PROGESTERONE RECEPTOR AND ALSO IN THE HIGH POTENCY JRNL TITL 3 OF 13-ETHYL PROGESTINS JRNL REF MOL.PHARMACOL. V. 75 1317 2009 JRNL REFN ISSN 0026-895X JRNL PMID 19289570 JRNL DOI 10.1124/MOL.108.054312

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. 2.26 ANGSTROMS.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.26 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.83 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1591596.980 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 80.9 REMARK 3 NUMBER OF REFLECTIONS : 20345 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.231 REMARK 3 FREE R VALUE : 0.279 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1058 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.26 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.30 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2864 REMARK 3 BIN R VALUE (WORKING SET) : 0.2300 REMARK 3 BIN FREE R VALUE : 0.2840 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 1058 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.054 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3967 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 352 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 26.34000 REMARK 3 B22 (A**2) : -9.62000 REMARK 3 B33 (A**2) : -16.72000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.22000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM SIGMAA (A) : 0.53 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.61 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.20 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.79 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.050 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.770 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.540 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.230 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 68.65 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : LEVO.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : LEVO.TOP REMARK 3 TOPOLOGY FILE 3 : WATER_REP.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL

REMARK 4 REMARK 4 3D90 COMPLIES WITH FORMAT V. 3.20, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 28-MAY-08. REMARK 100 THE RCSB ID CODE IS RCSB047743.

REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-FEB-06 REMARK 200 TEMPERATURE (KELVIN) : 78 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM30A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979738 REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED SI(111) REMARK 200 OPTICS : MIRROR 1, DOUBLE CRYSTAL, REMARK 200 MIRROR 2 REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20345 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.260 REMARK 200 RESOLUTION RANGE LOW (A) : 47.830 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 80.9 REMARK 200 DATA REDUNDANCY : 2.760 REMARK 200 R MERGE (I) : 0.08100 REMARK 200 R SYM (I) : 0.06700 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.1100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.26 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 73.5 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.41300 REMARK 200 R SYM FOR SHELL (I) : 0.33200 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.330 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1SQN REMARK 200 REMARK 200 REMARK: NULL

REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8% PEG3350, X300MM MGSO4, 10% REMARK 280 GLYCEROL 10%, 50MM PIPES, PH6.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293K

REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.65500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL

REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.

REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000

REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 676 REMARK 465 PRO A 677 REMARK 465 GLY A 678 REMARK 465 GLN A 679 REMARK 465 ASP A 680 REMARK 465 ILE A 681 REMARK 465 THR A 706 REMARK 465 LYS A 707 REMARK 465 LYS A 861 REMARK 465 LYS A 932 REMARK 465 LYS A 933 REMARK 465 SER B 676 REMARK 465 PRO B 677 REMARK 465 GLY B 678 REMARK 465 GLN B 679 REMARK 465 ASP B 680 REMARK 465 ILE B 681 REMARK 465 GLN B 682 REMARK 465 LYS B 861 REMARK 465 LYS B 933

REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 682 CG CD OE1 NE2 REMARK 470 LEU A 683 CG CD1 CD2 REMARK 470 ASP A 704 CG OD1 OD2 REMARK 470 ARG A 836 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 840 CG CD OE1 NE2 REMARK 470 LEU B 683 CG CD1 CD2 REMARK 470 VAL B 698 CG1 CG2 REMARK 470 THR B 706 OG1 CG2 REMARK 470 LYS B 707 CG CD CE NZ REMARK 470 LYS B 790 CG CD CE NZ REMARK 470 GLN B 812 CG CD OE1 NE2 REMARK 470 GLN B 868 CG CD OE1 NE2 REMARK 470 GLU B 911 CG CD OE1 OE2 REMARK 470 LYS B 932 CG CD CE NZ

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLY B 762 NH2 ARG B 766 1.86 REMARK 500 OD1 ASN A 828 NH1 ARG A 845 2.00 REMARK 500 O HOH B 3022 O HOH B 3092 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 708 CA - N - CD ANGL. DEV. = -8.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 704 -88.46 -93.17 REMARK 500 LEU A 782 78.85 -157.24 REMARK 500 MET A 789 68.70 -106.78 REMARK 500 SER A 837 57.06 -93.74 REMARK 500 MET A 924 37.00 -94.90 REMARK 500 LYS B 707 126.24 -171.91 REMARK 500 HIS B 770 -78.69 -112.38 REMARK 500 VAL B 771 26.72 -73.84 REMARK 500 LEU B 782 81.66 -161.84 REMARK 500 SER B 793 13.61 87.92 REMARK 500 PHE B 794 32.10 -161.38 REMARK 500 SER B 837 51.84 -92.14 REMARK 500 ARG B 859 -86.63 -144.33 REMARK 500 VAL B 863 -35.34 -142.72 REMARK 500 GLN B 916 -15.51 -141.28 REMARK 500 MET B 924 44.24 -90.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (11X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 ASP A 709 25.0 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL

REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B3078 DISTANCE = 6.14 ANGSTROMS REMARK 525 HOH A3079 DISTANCE = 5.33 ANGSTROMS REMARK 525 HOH B3182 DISTANCE = 5.02 ANGSTROMS REMARK 525 HOH B3229 DISTANCE = 5.86 ANGSTROMS REMARK 525 HOH A3148 DISTANCE = 5.43 ANGSTROMS REMARK 525 HOH B3262 DISTANCE = 6.38 ANGSTROMS REMARK 525 HOH A3167 DISTANCE = 5.98 ANGSTROMS REMARK 525 HOH A3175 DISTANCE = 5.41 ANGSTROMS REMARK 525 HOH B3288 DISTANCE = 5.72 ANGSTROMS REMARK 525 HOH A3187 DISTANCE = 5.31 ANGSTROMS REMARK 525 HOH A3256 DISTANCE = 5.75 ANGSTROMS REMARK 525 HOH A3326 DISTANCE = 7.22 ANGSTROMS REMARK 525 HOH A3342 DISTANCE = 5.95 ANGSTROMS REMARK 525 HOH A3343 DISTANCE = 6.13 ANGSTROMS

REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NOG A 1001 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NOG B 2001

DBREF 3D90 A 676 933 UNP P06401 PRGR_HUMAN 676 933 DBREF 3D90 B 676 933 UNP P06401 PRGR_HUMAN 676 933

SEQRES 1 A 258 SER PRO GLY GLN ASP ILE GLN LEU ILE PRO PRO LEU ILE SEQRES 2 A 258 ASN LEU LEU MET SER ILE GLU PRO ASP VAL ILE TYR ALA SEQRES 3 A 258 GLY HIS ASP ASN THR LYS PRO ASP THR SER SER SER LEU SEQRES 4 A 258 LEU THR SER LEU ASN GLN LEU GLY GLU ARG GLN LEU LEU SEQRES 5 A 258 SER VAL VAL LYS TRP SER LYS SER LEU PRO GLY PHE ARG SEQRES 6 A 258 ASN LEU HIS ILE ASP ASP GLN ILE THR LEU ILE GLN TYR SEQRES 7 A 258 SER TRP MET SER LEU MET VAL PHE GLY LEU GLY TRP ARG SEQRES 8 A 258 SER TYR LYS HIS VAL SER GLY GLN MET LEU TYR PHE ALA SEQRES 9 A 258 PRO ASP LEU ILE LEU ASN GLU GLN ARG MET LYS GLU SER SEQRES 10 A 258 SER PHE TYR SER LEU CYS LEU THR MET TRP GLN ILE PRO SEQRES 11 A 258 GLN GLU PHE VAL LYS LEU GLN VAL SER GLN GLU GLU PHE SEQRES 12 A 258 LEU CYS MET LYS VAL LEU LEU LEU LEU ASN THR ILE PRO SEQRES 13 A 258 LEU GLU GLY LEU ARG SER GLN THR GLN PHE GLU GLU MET SEQRES 14 A 258 ARG SER SER TYR ILE ARG GLU LEU ILE LYS ALA ILE GLY SEQRES 15 A 258 LEU ARG GLN LYS GLY VAL VAL SER SER SER GLN ARG PHE SEQRES 16 A 258 TYR GLN LEU THR LYS LEU LEU ASP ASN LEU HIS ASP LEU SEQRES 17 A 258 VAL LYS GLN LEU HIS LEU TYR CYS LEU ASN THR PHE ILE SEQRES 18 A 258 GLN SER ARG ALA LEU SER VAL GLU PHE PRO GLU MET MET SEQRES 19 A 258 SER GLU VAL ILE ALA ALA GLN LEU PRO LYS ILE LEU ALA SEQRES 20 A 258 GLY MET VAL LYS PRO LEU LEU PHE HIS LYS LYS SEQRES 1 B 258 SER PRO GLY GLN ASP ILE GLN LEU ILE PRO PRO LEU ILE SEQRES 2 B 258 ASN LEU LEU MET SER ILE GLU PRO ASP VAL ILE TYR ALA SEQRES 3 B 258 GLY HIS ASP ASN THR LYS PRO ASP THR SER SER SER LEU SEQRES 4 B 258 LEU THR SER LEU ASN GLN LEU GLY GLU ARG GLN LEU LEU SEQRES 5 B 258 SER VAL VAL LYS TRP SER LYS SER LEU PRO GLY PHE ARG SEQRES 6 B 258 ASN LEU HIS ILE ASP ASP GLN ILE THR LEU ILE GLN TYR SEQRES 7 B 258 SER TRP MET SER LEU MET VAL PHE GLY LEU GLY TRP ARG SEQRES 8 B 258 SER TYR LYS HIS VAL SER GLY GLN MET LEU TYR PHE ALA SEQRES 9 B 258 PRO ASP LEU ILE LEU ASN GLU GLN ARG MET LYS GLU SER SEQRES 10 B 258 SER PHE TYR SER LEU CYS LEU THR MET TRP GLN ILE PRO SEQRES 11 B 258 GLN GLU PHE VAL LYS LEU GLN VAL SER GLN GLU GLU PHE SEQRES 12 B 258 LEU CYS MET LYS VAL LEU LEU LEU LEU ASN THR ILE PRO SEQRES 13 B 258 LEU GLU GLY LEU ARG SER GLN THR GLN PHE GLU GLU MET SEQRES 14 B 258 ARG SER SER TYR ILE ARG GLU LEU ILE LYS ALA ILE GLY SEQRES 15 B 258 LEU ARG GLN LYS GLY VAL VAL SER SER SER GLN ARG PHE SEQRES 16 B 258 TYR GLN LEU THR LYS LEU LEU ASP ASN LEU HIS ASP LEU SEQRES 17 B 258 VAL LYS GLN LEU HIS LEU TYR CYS LEU ASN THR PHE ILE SEQRES 18 B 258 GLN SER ARG ALA LEU SER VAL GLU PHE PRO GLU MET MET SEQRES 19 B 258 SER GLU VAL ILE ALA ALA GLN LEU PRO LYS ILE LEU ALA SEQRES 20 B 258 GLY MET VAL LYS PRO LEU LEU PHE HIS LYS LYS

HET NOG A1001 23 HET NOG B2001 23

HETNAM NOG 13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN- HETNAM 2 NOG 3-ONE

HETSYN NOG NORGESTREL

FORMUL 3 NOG 2(C21 H28 O2) FORMUL 5 HOH *352(H2 O)

HELIX 1 1 PRO A 685 ILE A 694 1 10 HELIX 2 2 THR A 710 LYS A 734 1 25 HELIX 3 3 GLY A 738 LEU A 742 5 5 HELIX 4 4 HIS A 743 VAL A 771 1 29 HELIX 5 5 ASN A 785 MET A 789 5 5 HELIX 6 6 GLU A 791 TRP A 802 1 12 HELIX 7 7 TRP A 802 GLN A 812 1 11 HELIX 8 8 SER A 814 LEU A 827 1 14 HELIX 9 9 SER A 837 GLY A 857 1 21 HELIX 10 10 VAL A 863 ASN A 879 1 17 HELIX 11 11 ASN A 879 GLN A 897 1 19 HELIX 12 12 PRO A 906 ALA A 922 1 17 HELIX 13 13 PRO B 685 ILE B 694 1 10 HELIX 14 14 THR B 710 LEU B 736 1 27 HELIX 15 15 GLY B 738 LEU B 742 5 5 HELIX 16 16 HIS B 743 HIS B 770 1 28 HELIX 17 17 ASN B 785 GLU B 791 1 7 HELIX 18 18 PHE B 794 GLN B 812 1 19 HELIX 19 19 SER B 814 LEU B 827 1 14 HELIX 20 20 SER B 837 LEU B 858 1 22 HELIX 21 21 VAL B 863 GLN B 897 1 35 HELIX 22 22 GLN B 897 SER B 902 1 6 HELIX 23 23 PRO B 906 GLY B 923 1 18

SHEET 1 A 2 LEU A 776 ALA A 779 0 SHEET 2 A 2 LEU A 782 LEU A 784 -1 O LEU A 782 N ALA A 779 SHEET 1 B 2 THR A 829 ILE A 830 0 SHEET 2 B 2 LYS A 926 PRO A 927 -1 O LYS A 926 N ILE A 830 SHEET 1 C 2 LEU B 776 ALA B 779 0 SHEET 2 C 2 LEU B 782 LEU B 784 -1 O LEU B 784 N LEU B 776 SHEET 1 D 2 THR B 829 ILE B 830 0 SHEET 2 D 2 LYS B 926 PRO B 927 -1 O LYS B 926 N ILE B 830

SITE 1 AC1 10 LEU A 715 LEU A 718 ASN A 719 LEU A 721 SITE 2 AC1 10 GLN A 725 MET A 759 ARG A 766 LEU A 887 SITE 3 AC1 10 TYR A 890 CYS A 891 SITE 1 AC2 10 LEU B 715 LEU B 718 ASN B 719 LEU B 721 SITE 2 AC2 10 GLN B 725 MET B 759 ARG B 766 LEU B 887 SITE 3 AC2 10 CYS B 891 PHE B 905

CRYST1 58.870 65.310 70.620 90.00 96.01 90.00 P 1 21 1 4

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 0.016987 0.000000 0.001788 0.00000

SCALE2 0.000000 0.015312 0.000000 0.00000

SCALE3 0.000000 0.000000 0.014239 0.00000